Pharmacological treatment of frontotemporal dementia: treatment response to the MAO-A inhibitor moclobemide

被引：23

作者：

Adler, G ^{[1
]}

Teufel, M

Drach, LM

机构：

[1] Zent Inst Seel Gesundheit, Altentagesklin, D-68159 Mannheim, Germany

[2] Carl Friedrich Flemming Klin, Abt Alterspsychiat, Schwerin, Germany

来源：

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY | 2003年 / 18卷 / 07期

关键词：

D O I：

10.1002/gps.894

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

[No abstract available]

引用

页码：653 / 655

页数：3

共 5 条

[1]

ANDERSON IM, 1995, AM J PSYCHIAT, V152, P645

[2] Clinical and pathological diagnosis of Frontotemporal Dementia - Report of the work group on Frontotemporal Dementia and Pick's disease [J].

McKhann, GM ;

Albert, MS ;

Grossman, M ;

Miller, B ;

Dickson, D ;

Trojanowski, JQ .

ARCHIVES OF NEUROLOGY, 2001, 58 (11) :1803-1809

[3] Frontotemporal dementia: Paroxetine as a possible treatment of behavior symptoms - A randomized, controlled, open 14-month study [J].

Moretti, R ;

Torre, P ;

Antonello, RM ;

Cazzato, G ;

Bava, A .

EUROPEAN NEUROLOGY, 2003, 49 (01) :13-19

[4] Effects of selegiline on fronto-temporal dementia: a neuropsychological evaluation [J].

Moretti, R ;

Torre, P ;

Antonello, RM ;

Cazzato, G ;

Bava, A .

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (04) :391-392

[5] Frontotemporal dementia: Treatment response to serotonin selective reuptake inhibitors [J].

Swartz, JR ;

Miller, BL ;

Lesser, IM ;

Darby, AL .

JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (05) :212-216

← 1 →